Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe history log now shows a new revision v3.6.6 added and the previous v3.6.5 removed, indicating a version update to the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe history now shows Revision: v3.6.5, replacing the previous v3.6.4. This reflects a new build of the page's revision history rather than changes to the study data.SummaryDifference0.1%

- Check38 days agoChange DetectedA new revision entry (v3.6.4) was added to the study history, replacing the previous version (v3.6.3) and documenting an updated version of the record.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry v3.6.3 is added to the study record history, replacing the previous v3.6.2, signaling an update to the page’s version for this study record.SummaryDifference0.1%

- Check67 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history. The earlier revision (v3.6.0) was removed from the visible history, updating the record's version history.SummaryDifference0.1%

- Check81 days agoChange DetectedRecruitment status was updated to not recruiting. The history now shows a new revision: v3.6.0, with the prior revision v3.5.5 removed.SummaryDifference0.4%

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.